New HIV prevention pill tested with TB treatment
NCT ID NCT07600775
First seen May 23, 2026 · Last updated May 23, 2026
Summary
This early-stage study tests how a new HIV prevention drug (MK-8527) interacts with rifampin, a medicine for latent tuberculosis. Fourteen adults with latent TB will take both drugs, and researchers will measure drug levels in the blood. The goal is to see if the drugs can be used together safely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV PRE-EXPOSURE PROPHYLAXIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.